Titlebook: Regulating Preimplantation Genetic Diagnosis in the United States; The Limits of Unlimi Michelle Bayefsky,Bruce Jennings Book 2015 Palgrave

Clinch

Palgrave Macmillan, a division of Nature America Inc. 2015

不適當(dāng)

Regulating Preimplantation Genetic Diagnosis in the United States978-1-137-51544-5Series ISSN 2945-6738 Series E-ISSN 2945-6746

同來(lái)核對(duì)

Paying for PGD,at insurance companies consider when deciding whether to offer coverage for PGD and for what purposes. The chapter ends with a brief recapitulation of the major conclusions of the essay and several avenues for future research.

混合,攙雜

2945-6738 s many ethical questions but is virtually unregulated in the United States. This comprehensive study considers the ethical, medical, political, and economic aspects of developing appropriate regulation.978-1-137-51544-5Series ISSN 2945-6738 Series E-ISSN 2945-6746

使人入神

Pillory

The Ethics of PGD and Its Relevance to Regulation,s “Should we be doing this at all?” and “What is a life worth living?” In Chapter 2, we discuss a number of general criticisms and defenses of the desire for control and choice that biotechnology generally and PGD in particular raise. We also begin to discuss a range of uses of PGD, including the av

neoplasm

ironic

Aphorism

CANT

Introduction,ncludes a description of the current regulatory landscape for PGD in the United States as compared to two Western European countries (the UK and France), and ends with a discussion of the relationships between health care financing in the United States, insurance coverage of PGD, and the current dearth of regulation.